维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Carlander D"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Avian antibodies can eliminate interference due to complement activation in ELISA显示文摘	Carlander D Larsson A	2001	Ups J Med Sci2001，106，2：	1
2	Oral administration of specific yolk antibodies(IgY)may prevent pseudomonas aeruginosa infections in patients with cystic fibrosis:A phase I feasibility study显示文摘	Kollberg H Carlander D Olesen H	2003	Pediatr Pulmonol2003，35，6：	1
3	Chicken antibodies: a clinical chemistry perspective显示文摘	Carlander D Stalberg J Larsson A	1999	Ups J Med Sci1999，104，3：	1
4	Farm Fish Pond Research in Iowa显示文摘	Carlander K D	1952	The Journal of Wildlife Management1952，16，3：	1
5	Limited day to day variation of IgY levels in eggs from individual laying hens显示文摘	Carlander D Wilhelmson M Larsson A	2001	Food and Agricultural Immunology2001，13，2：	1
6	Limited day to day variation of IgY levels in eggs from individual laying hens显示文摘	Carlander D Wilhelmson M Larsson A	2001	Food and Agricultural Immunology2001，13，2：	1
7	Risk benefit health assessment of food Food fortification and nitrate in vegetables显示文摘	Bottex B Dorne J L C M Carlander D	2008	Trends Food Sci Tecbnol2008，19，1：	1
8	Retention of specific yolk IgY in human oral cavity 显示文摘	Carlander D Kollberg H Larsson A		Biodrugs0，16，6：	1
9	Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections显示文摘	Carlander D Kollberg H	2000	Immunol Res2000，21，：	1
10	Exploring the Existence of Entrepreneurial Teams显示文摘	ENSLEY M D CARLAND J C CARLAND J W BANKS M	1999	International Journal of Management1999，16，27：	1
11	Oral administration of specific yolk antibodies(IgY)may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis:A phase Ⅰ feasibility study显示文摘	Kollberg H Carlander D Olesen H	2003	Pediatr Pulmonol2003，35，6：	1
12	Oral administrati-on of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study显示文摘	Kollberg H Carlander D Olesen H	2003	Pediatr Pulmonol2003，35，6：	1
13	Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infection显示文摘	Kollberg H Wajaker P E	2000	Immunol Res2000，21，：	1
14	Preferential transposition of the maize element Activator to linked chromosomallocations in tobacco显示文摘	JONES J D G CARLAND F LIM E RALSTON E		0，，：	1
15	Peroral immuno- therapy with yolk antibodies for the prevention and treatment of enteric infections 显示文摘	Carlander D Kollberg H Wejaker PE	2000	lmmunol Res2000，21，1：	1
16	Peroral immunotherapy with yolk antebodies for the prevention and treatment of enteric infections显示文摘	Carlander D Kollberg H Wejaker PE	2000	Immunol Res2000，21，：	1
17	Retention of specific yolk IgY in the human oral cavity 显示文摘	Carlander D Kollberg H Larsson A	2002	Bio Drugs2002，16，6：	1
18	Effective vectors for transformation,expression of heterologous genes,and assaying transposon excision in transgenic plants显示文摘	JONES J D SHLUMUKOV L CARLAND F	1992	Transgenic Res1992，1，6：	1
19	Avian antibodies can eliminate interference due to complement activation in ELISA 显示文摘	Carlander D Larsson A	2001	Ups J Med Sei2001，106，：	1
20	The effects of entrepreneurial team skill heterogeneity and functional diversity on new venture performance 显示文摘	ENSLEY M D CARLAND J C CARLAND J W	1998	Journal of Business and Entrepreneurship1998，10，1：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示